Programmed death ligand-1 (PD-L1) is an immune checkpoint molecule expressed on a wide range of cancer cells that allows them to evade immunosurveillance via interaction with programmed death-1 (PD-1) [6]. This evidence concerns the gene CD274 and cancer.